Related Experiment Video
Updated: Nov 12, 2025

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
AMPK protects against alcohol-induced liver injury through UQCRC2 to up-regulate mitophagy
Xinyi Lu1, Wenting Xuan2, Juanjuan Li1
1Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China.
Abstract:
Recent reports indicated that mitophagy protects against alcohol-induced liver injury, which helps remove damaged mitochondria to reduce the accumulation of reactive oxygen species (ROS). AMP-activated protein kinase (AMPK) has been recently used in ALD (alcoholic liver disease) and mitochondrial dysfunction research. However, the inner mechanism, whether AMPK can regulate mitophagy in ALD, remains unknown. Here we found that AMPK can significantly reduce alcohol-induced liver injury and enhances hepatocytes' mitophagy level. Next, we identified that AMPK rescued alcohol-induced low expression of UQCRC2 (ubiquinol-cytochrome c reductase core protein 2). Interestingly, UQCRC2 knockdown (KD) treatment causes impaired mitophagy, whereas UQCRC2 overexpression (OE) can significantly increase mitophagy to attenuate liver injury. Also, we identified that AMPK indirectly upregulates UQCRC2 protein level, and RNA-seq, chromatin immunoprecipitation (ChIP) assay, bioinformatics, and luciferase assays helped us understand that AMPK enhanced UQCRC2 gene transcription through activating NFE2L2/NRF2 (nuclear factor, erythroid 2 like 2). Our results demonstrate that AMPK regulating UQCRC2 is a significant mitochondrial event in mitophagy. It identifies a new signaling axis, AMPK-NFE2L2-UQCRC2, in the regulation of mitophagy levels in the liver, suggesting a possible therapeutic strategy to treat ALD.Abbreviations: AAV: AENO-associated virus; ALD: alcoholic liver disease; AMPK: AMP-activated protein kinase; BUN: blood urea nitrogen; H&E: hematoxylin and eosin; CCCP: carbonyl cyanide 3-chlorophenylhydrazone; ChIP: chromatin immunoprecipitation assay; CO-IP: co-immunoprecipitation; COPD: chronic obstructive pulmonary disease; EM: electron microscope; GOT1/AST: glutamic-oxaloacetic transaminase 1; GPT/ALT: glutamic-pyruvic transaminase; IF: immunofluorescence; IHC: immunohistochemistry; KD: knockdown; MAP1LC3/LC3: microtubule associated protein 1 light chain protein 3; MTDR: MitoTracker Deep Red; NFE2L2/NRF2: nuclear factor, erythroid 2 like 2; mtDNA: mitochondrial DNA; MTRC: MitoTracker Red CMXRos; OCR: Oxygen consumption rate; OE: overexpress; PINK1: PTEN induced kinase 1; qRT-PCR: quantitative real-time PCR; ROS: reactive oxygen species; SD: standard deviation; SOD2: superoxide dismutase 2; UQCRC2: ubiquinol-cytochrome c reductase core protein 2; WB: western blot; ΔΨ: mitochondrial membrane potential.
Insights
AMP-activated protein kinase (AMPK) protects against alcoholic liver disease by enhancing mitophagy. AMPK activates the NFE2L2-UQCRC2 pathway, improving mitochondrial function and reducing liver injury.
Area of Science:
- * Molecular Biology
- * Cellular Biology
- * Hepatology
Background:
- * Mitophagy is crucial for removing damaged mitochondria and reducing reactive oxygen species (ROS), offering protection against alcohol-induced liver injury.
- * AMP-activated protein kinase (AMPK) is implicated in alcoholic liver disease (ALD) and mitochondrial dysfunction, but its role in regulating mitophagy in ALD is unclear.
Purpose of the Study:
- * To investigate the mechanism by which AMPK regulates mitophagy in alcoholic liver disease.
- * To identify key molecular players in the AMPK-mediated mitophagy pathway relevant to ALD.
Main Methods:
- * Investigated the effect of AMPK activation on alcohol-induced liver injury and hepatocyte mitophagy.
- * Utilized knockdown (KD) and overexpression (OE) of UQCRC2 to assess its role in mitophagy.
- * Employed RNA-seq, chromatin immunoprecipitation (ChIP) assays, bioinformatics, and luciferase assays to elucidate gene transcription regulation.
Main Results:
- * AMPK activation significantly reduced alcohol-induced liver injury and enhanced hepatocyte mitophagy.
- * AMPK rescued alcohol-induced downregulation of UQCRC2, a protein critical for mitophagy.
- * UQCRC2 knockdown impaired mitophagy, while overexpression attenuated liver injury.
- * AMPK was found to indirectly upregulate UQCRC2 protein levels by enhancing its gene transcription via the AMPK-NFE2L2/NRF2 signaling axis.
Conclusions:
- * AMPK plays a protective role in alcoholic liver disease by promoting mitophagy.
- * The novel signaling axis AMPK-NFE2L2-UQCRC2 is identified as a key regulator of mitophagy in the liver.
- * Targeting this pathway presents a potential therapeutic strategy for treating alcoholic liver disease.
More Related Videos
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Unfolded Protein Response
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
PI3K/mTOR/AKT Signaling Pathway
Regulation of the Unfolded Protein Response
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...